Company intelligence
OncoOptima
Cancer Care Intelligence.
Biotechnology Research
Chicago, US
3 employees
1 public signals
About OncoOptima
We built OncoOptima after losing our fathers to cancer. We built this for the moment when someone has been told they have multiple treatment options — and the options look similar on paper. That's the window we work in. OncoChoice tests a patient's cancer cells against the treatments their care team is considering, to rule out what is unlikely to work before treatment begins.
Verified activity
Signals from OncoOptima
1 published signal